Medasense for pain management and Vectorious for heart-failure monitoring were among 50 companies selected from a field of 800 applicants.
Israeli biomed companies Medasense and Vectorious were among 50 best-in-class device, diagnostics, and digital health technologies chosen forMedTech Innovator’s 2019 Showcase program, presented at the Wilson Sonsini Goodrich & Rosati’s 27th Annual Medical Device Conference in San Francisco last June, and at the coming MedTech Conference in Boston, September 23-25.
The 50 finalists were selected out of 800 applicants during a six-month diligence process by Los Angeles-based MedTech Innovator and its 19 corporate partners.
After reviewing all applicants, the 200 judges traveled around the world to meet 150 shortlisted candidate startups in person and choose those that will participate in the showcase, an on-stage interactive program.